Figure 4.
α-LacCer suppresses α-GalCer and GSL-1-induced airway hyperreactivity. BALB/c mice were treated intranasally with 1 μg α-GalCer (A–C) or 10 μg GSL-1 (D) in the presence or absence of 1 μg α-LacCer for 24 h. (A,D) Changes in lung resistance (RL) in response to increasing doses of methacholine [n = 6–8/group in (A); n = 3–5/group in (D)]. (B) The numbers of macrophage (Mac), neutrophil (Neu), eosinophil (Eos), and lymphocyte (Lym) in the BALF (n = 7–8). (C) The levels of IL-4 and IL-13 in the lungs assessed using ELISA (n = 4). Data are representative of three independent experiments and presented as means ± s.e.m. [*P < 0.05, **P < 0.01, and ***P < 0.001; Two-way ANOVA (A,D) and Student's t-test (B,C)].